Overview

  • Product name
  • Description
    Goat polyclonal to SUMF1
  • Tested applications
    Suitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Rat, Cow, Dog
  • Immunogen

    Synthetic peptide:

    C-ETLNPKGPPSGKDR

    , corresponding to internal sequence amino acids 314-327 of Human SUMF1 (NP_877437.2).

  • Positive control
    • Mouse pancreas, Mouse eye and Human kidney lysates

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
  • Storage buffer
    Preservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris buffered saline, pH 7.3
  • Concentration information loading...
  • Purity
    Immunogen affinity purified
  • Purification notes
    ab91479 is purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • Clonality
    Polyclonal
  • Isotype
    IgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab91479 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
  • Application notes
    WB: Use at a concentration of 0.5 - 2 µg/ml. Detects a band of approximately 37 kDa (predicted molecular weight: 40 kDa).


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Function
      Using molecular oxygen and an unidentified reducing agent, oxidizes a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also called C(alpha)-formylglycine. Known substrates include GALNS, ARSA, STS and ARSE.
    • Tissue specificity
      Ubiquitous. Highly expressed in kidney, pancreas and liver. Detected at lower levels in leukocytes, lung, placenta, small intestine, skeletal muscle and heart.
    • Pathway
      Protein modification; sulfatase oxidation.
    • Involvement in disease
      Defects in SUMF1 are the cause of multiple sulfatase deficiency (MSD) [MIM:272200]. MSD is a clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay. Inheritance is autosomal recessive.
    • Sequence similarities
      Belongs to the sulfatase-modifying factor family.
    • Post-translational
      modifications
      N-glycosylated. Contains high-mannose-type oligosaccharides.
    • Cellular localization
      Endoplasmic reticulum lumen.
    • Information by UniProt
    • Database links
    • Alternative names
      • MGC150436 antibody
      • AAPA3037 antibody
      • C alpha formylglycine generating enzyme 1 antibody
      • C-alpha-formylglycine-generating enzyme 1 antibody
      • FGE antibody
      • FGly generating enzyme antibody
      • MGC131853 antibody
      • Sulfatase modifying factor 1 [Precursor] antibody
      • Sulfatase-modifying factor 1 antibody
      • SUMF1 antibody
      • SUMF1_HUMAN antibody
      • UNQ3037 antibody
      see all

    Anti-SUMF1 antibody images

    References for Anti-SUMF1 antibody (ab91479)

    ab91479 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab91479.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up